Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
The doxorubicin-selected lung cancer cell line H69AR is resistant to many chemotherapeutic agents. However, like most tumor samples from individuals with this disease, it does not overexpress P-glycoprotein, a transmembrane transport protein that is dependent on adenosine triphosphate (ATP) and is associated with multidrug resistance. Complementary DNA (cDNA) clones corresponding to messenger RNAs (mRNAs) overexpressed in H69AR cells were isolated. One cDNA hybridized to an mRNA of 7.8 to 8.2 kilobases that was 100- to 200-fold more expressed in H69AR cells relative to drug-sensitive parental H69 cells. Overexpression was associated with amplification of the cognate gene located on chromosome 16 at band p13.1. Reversion to drug sensitivity was associated with loss of gene amplification and a marked decrease in mRNA expression. The mRNA encodes a member of the ATP-binding cassette transmembrane transporter superfamily.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The overexpression of ABCC1 in tumor cells has been implicated in the multidrug-resistant phenotype caused by cytotoxic drugs (60).”
From SRC kinase drives multidrug resistance induced by KRAS-G12C inhibition (2024) · cites this paper as [60]
In the citing paper
“ABCC1, which was originally cloned from the human small cell lung cancer cell line H69AR (60), is known to transport a variety of endogenous substrates, such as the antioxidant glutathione and pro-inflammatory leukotrienes (65).”
From SRC kinase drives multidrug resistance induced by KRAS-G12C inhibition (2024) · cites this paper as [60]
In the citing paper
“To date, at least 15 human ABC superfamily transporters, including ABCB1 (59), ABCC1 (60), and ABCG2 (61), have been reported to mediate multidrug resistance in different circumstances, including G12Ci treatment (27, 62, 63).”
From SRC kinase drives multidrug resistance induced by KRAS-G12C inhibition (2024) · cites this paper as [60]
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,887
A comprehensive set of sequence analysis programs for the VAX
Devereux, J., Haeberli, P., & Smithies, O. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.1part1.387 · Cited by 14,222
Improved tools for biological sequence comparison.
Pearson, W. R., & Lipman, D. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.8.2444 · Cited by 11,227
Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA
Riordan, J. R., Rommens, J. M., Kerem, B.-S., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J.-L., et al. (1989) · Science · doi:10.1126/science.2475911 · Cited by 7,418
Walker, J. E., Saraste, M., Runswick, M. J., & Gay, N. J. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01276.x · Cited by 5,312
Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., & Willingham, M. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7735 · Cited by 2,777
Chen, C.-J., Chin, J. E., Ueda, K., Clark, D. P., Pastan, I., Gottesman, M. M., & Roninson, I. B. (1986) · Cell · doi:10.1016/0092-8674(86)90595-7 · Cited by 1,898
Progressive sequence alignment as a prerequisitetto correct phylogenetic trees
Feng, D.-F., & Doolittle, R. F. (1987) · Journal of Molecular Evolution · doi:10.1007/bf02603120 · Cited by 1,883
Cordon-Cardo, C., O'Brien, J. P., Casals, D., Rittman-Grauer, L., Biedler, J. L., Melamed, M. R., & Bertino, J. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.695 · Cited by 1,750
Research works printed but not linked: 3
- GERLACH, J.H., MULTIDRUG RESISTANCE, CANCER SURVEYS 5: 25 (1986).
- UEYAMA, H, STRUCTURE OF A HUMAN SMOOTH-MUSCLE ACTIN GENE (AORTIC TYPE) WITH A UNIQUE INTRON SITE, MOLECULAR AND CELLULAR BIOLOGY 4: 1073 (1984).
- VANDERBLIEK, A.M., OVEREXPRESSION AND AMPLIFICATION OF 5 GENES IN A MULTIDRUG-RESISTANT CHINESE-HAMSTER OVARY CELL-LINE, MOLECULAR AND CELLULAR BIOLOGY 6: 1671 (1986).
Cited by
Items 801–900 of 1,012
Huang, X., Xiao, X., Zhang, Y., Talele, T. T., Salim, A. A., Chen, Z., & Capon, R. J. (2014) · Marine Drugs · doi:10.3390/md12073818 · Cited by 79
“Historically, the over-expression of three ATP binding cassette (ABC) transporters, P-glycoprotein (P-gp) [1,2], breast cancer resistant protein (BCRP) [3] and/or multi-drug resistance protein 1 (MRP1) [4], have been correlated with many occurrences of MDR.”
BackgroundHaimeur, A., Deeley, R. G., & Cole, S. P. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206228200 · Cited by 78
Self-citationEffect of the breast-cancer resistance protein on atypical multidrug resistance
Lage, H., & Dietel, M. (2000) · The Lancet Oncology · doi:10.1016/s1470-2045(00)00032-2 · Cited by 83
van der Kolk, D. M., de Vries, E., Noordhoek, L., van den Berg, E., van der Pol, M., Müller, M. M., & Vellenga, E. (2001) · Leukemia · doi:10.1038/sj.leu.2402236 · Cited by 79
Choudhuri, S. P., Girard, L., Lim, J. Y. S., Wise, J. F., Freitas, B., Yang, D., Wong, E., Hamilton, S., Chien, V. D., Kim, Y. J., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-0656 · Cited by 87
“Promising candidates include the upregulation of multidrug-resistance efflux pumps (64), soluble guanylate cyclase (sGC; ref.”
Vulsteke, C., Pfeil, A. M., Maggen, C., Schwenkglenks, M. M., Pettengell, R., Szucs, T. D., Lambrechts, D., Dieudonné, A.-S., Hatse, S., Neven, P., et al. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3437-9 · Cited by 77
“The human ABCC1 gene is mainly involved in energy-dependent transport of cytotoxic agents out of the cell [31], it is a membrane-bound glycoprotein that is almost ubiquitously expressed in different cell types, including anthracyclineresistant tumor cells [32, 33].”
BackgroundDrug-resistant human lung cancer cells are more sensitive to selenium cytotoxicity
Björkhem‐Bergman, L., Jönsson, K., Eriksson, L. C., Olsson, J. M., Lehmann, S., Paul, C., & Björnstedt, M. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)00981-4 · Cited by 77
Lee, T., Ho, I., Lu, W.-J., & Huang, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601266200 · Cited by 81
Stefan, S. M., & Wiese, M. (2018) · Medicinal Research Reviews · doi:10.1002/med.21510 · Cited by 85
(2000) · Nature Biotechnology · doi:10.1038/80051 · Cited by 86
KEPPLER, D. O. R., Kamisako, T., Leier, I., Cui, Y., Nies, A. T., Tsujii, H., & König, J. (2000) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(99)00022-9 · Cited by 77
Zhang, L., Gorset, W., Washington, C. B., Blaschke, T. F., Kroetz, D. L., & Giacomini, K. M. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15369-x · Cited by 87
“L05628) (Cole et al., 1992).”
Immunosuppressors and reversion of multidrug-resistance
Aouali, N., Eddabra, L., Macadré, J., & Morjani, H. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.12.010 · Cited by 76
Furumoto, K., Arii, S., Yamasaki, S., Mizumoto, M., Mori, A., Inoue, N., Isobe, N., & Imamura, M. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000901)87:5<680::aid-ijc10>3.0.co;2-p · Cited by 52
Barrand, M. A., Bagrij, T., & Neo, S.-Y. (1997) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(96)00284-4 · Cited by 84
The role of the MDR protein in altered drug translocation across tumor cell membranes
Roepe, P. D. (1995) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(95)00013-5 · Cited by 86
SUN, L., Chen, W., Qu, L., Wu, J., & Jin, S. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1742 · Cited by 77
Modulation of GSH levels in ABCC1 expressing tumor cells triggers apoptosis through oxidative stress
Laberge, R.-M., Karwatsky, J., Lincoln, M. C., Leimanis, M. L., & Georges, E. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.02.005 · Cited by 90
“normal tissues, with higher levels in lung, kidney, testis and blood mononuclear cells [6,7].”
BackgroundInfluentialVulsteke, C., Lambrechts, D., Dieudonné, A. S., Hatse, S., Brouwers, B. A. H., Brussel, T. V., Neven, P., Belmans, A., Schöffski, P., Paridaens, R., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt008 · Cited by 75
Multidrug Resistance-Associated Protein-1 Functional Activity in Calu-3 Cells
Hamilton, K. O., Topp, E. M., Makagiansar, I. T., Siahaan, T. J., Yazdanian, M., & Audus, K. L. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29493-3 · Cited by 75
“MRP1 shares 15 and 19% homology to both these genes (Cole et al., 1992).”
Synthesis and Applications of Stimuli‐Responsive DNA‐Based Nano‐ and Micro‐Sized Capsules
Liao, W., & Willner, I. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201702732 · Cited by 76
Reversal of the resistance to STI571 in human chronic myelogenous leukemia K562 cells
Mukai, M., Che, X., Furukawa, T., Sumizawa, T., Aoki, S., Ren, X., Haraguchi, M., Sugimoto, Y., Kobayashi, M., Takamatsu, H., et al. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01482.x · Cited by 81
Different Pattern of MRP Localization in Ciliated and Basal Cells from Human Bronchial Epithelium
Bréchot, J.-M., Hurbain, I., Fajac, A., Daty, N., & Bernaudin, J. (1998) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549804600411 · Cited by 75
Zaman, G. J. R., Cnubben, N. H. P., van BLADEREN, P. J., Evers, R., & Borst, P. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00718-1 · Cited by 89
Multidrug resistance-associated protein in acute myeloid leukemia: No impact on treatment outcome.
Filipits, M., Suchomel, R. W., Zöchbauer‐Müller, S., Brunner, R., Lechner, K., & Pirker, R. (1997) · PubMed · Cited by 75
Gonçalves, B. M. F., Cardoso, D., & Ferreira, M. U. (2020) · Molecules · doi:10.3390/molecules25153364 · Cited by 86
“The MRP1 transporter was first identified in 1992 in doxorubicin H69AR lung carcinoma resistant cell line, where no P-gp expression was detected [24].”
BackgroundMolecular Mechanisms of Anthracycline Activity
Beretta, G. L., & Zunino, F. (2007) · Topics in current chemistry · doi:10.1007/128_2007_3 · Cited by 103
Identification of the Anopheles gambiae ATP-binding Cassette Transporter Superfamily Genes
Roth, C. W., Holm, I., Graille, M., Dehoux, P., Rzhetsky, A., Wincker, P., Weissenbach, J., & Brey, P. T. (2003) · Molecules and Cells · doi:10.1016/s1016-8478(23)13721-6 · Cited by 81
“A cDNA representing this gene was initially cloned from a human small cell lung cancer line resistant to several different anti-tumor drugs (Cole et al., 1992).”
BackgroundKis, E.-É., Nagy, T., Jani, M., Molnar, E. M., Jánossy, J., Ujhellyi, O., Német, K., Herédi‐Szabó, K., & Krajcsi, P. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.086264 · Cited by 78
miR‐7 modulates chemoresistance of small cell lung cancer by repressing MRP 1/ ABCC 1
Liu, H., Wu, X., Huang, J., Peng, J., & Guo, L. (2015) · International Journal of Experimental Pathology · doi:10.1111/iep.12131 · Cited by 74
Epitope mapping of monoclonal antibodies specific for the 190-kDa multidrug resistance protein (MRP)
Hipfner, D., Gao, M., Scheffer, G., Scheper, R., Deeley, R., & Cole, S. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.642 · Cited by 74
Self-citationFernández, S. B. M., Holló, Z., Kern, A., Bakos, É., Fischer, P. A., Borst, P., & Evers, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204267200 · Cited by 74
Nooter, K., Bosman, F. T., Burger, H., van Wingerden, K. E., Flens, M. J., Scheper, R. J., Oostrum, R. G., Boersma, A. W. M., van der Gaast, A., & Stoter, G. (1996) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a010484 · Cited by 84
Priebe, W., Krawczyk, M., Kuo, M. T., Yamane, Y., Savaraj, N., & Ishikawa, T. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8887 · Cited by 74
Ivy, S. P., Olshefski, R., Taylor, B. J., Patel, K., & Reaman, G. (1996) · Blood · doi:10.1182/blood.v88.1.309.309 · Cited by 80
Eriksson, H., Lengqvist, J., Hedlund, J., Uhlén, K., Orre, L. M., Bjellqvist, B., Persson, B., Lehtiö, J., & Jakobsson, P. (2008) · PROTEOMICS · doi:10.1002/pmic.200800174 · Cited by 73
“The primary resistance mechanism suggested for H69AR is through an upregulation of the multidrug resistance-associated protein 1 (MRP1), which is one of the most important members of the ATP-binding cassette (ABC) protein family acting as drugefflux systems [13].”
BackgroundAntitumor Drugs and Their Targets
Dembić, Z. (2020) · Molecules · doi:10.3390/molecules25235776 · Cited by 80
Implications of ABC transporters on the disposition of typical veterinary medicinal products
Schrickx, J. A., & Fink‐Gremmels, J. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.03.014 · Cited by 86
Gold nanoparticles and fluorescently-labelled DNA as a platform for biological sensing
Heuer‐Jungemann, A., Harimech, P. K., Brown, T., & Kanaras, A. G. (2013) · Nanoscale · doi:10.1039/c3nr03707j · Cited by 79
Multiple molecular targets in breast cancer therapy by betulinic acid
Luo, R., Fang, D., Chu, P., Wu, H., Zhang, Z., & Tang, Z. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.10.018 · Cited by 79
Development of precision medicine approaches based on inter-individual variability of BCRP/ABCG2
Chen, L., Manautou, J. E., Rasmussen, T. P., & Zhong, X. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.01.007 · Cited by 73
Expression of Multidrug Resistance-associated Protein (MRP) in Human Gliomas
Mohri, M., Nitta, H., & Yamashita, J. (2000) · Journal of Neuro-Oncology · doi:10.1023/a:1026528926482 · Cited by 76
Morrow, C. (1998) · Carcinogenesis · doi:10.1093/carcin/19.1.109 · Cited by 73
Yanase, K., Tsukahara, S., Mitsuhashi, J., & Sugimoto, Y. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.04.039 · Cited by 81
Vanhoefer, U. J., Cao, S., Harstrick, A., Seeber, S., & Rustum, Y. M. (1997) · Annals of Oncology · doi:10.1023/a:1008290406221 · Cited by 82
“Recently, MDR has also been associated with expression of a Mr 190,000 membrane phosphoglycoprotein [16-19], designated MRP [16].”
BackgroundMethodHaber, M., Bordow, S. B., Gilbert, J., Madafiglio, J., Kavallaris, M., Marshall, G., Eb, M., Fruehauf, J., Tee, L. B. G., Cohn, S. L., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202859 · Cited by 73
“A candidate target gene for regulation by MYCN is the MRP gene (Cole et al., 1992) which encodes a transmembrane glycoprotein that is capable of conferring resistance to a wide range of structurally unrelated hydrophobic drugs by acting as a drug e ux pump (Zaman et al., 1994).”
BackgroundPas de Deux or More: the Sulfonylurea Receptor and K + Channels
Philipson, L. H., & Steiner, D. F. (1995) · Science · doi:10.1126/science.7716539 · Cited by 83
The P-glycoprotein-related gene family in Leishmania
Légaré, D., Hettema, E. H., & Ouellette, M. (1994) · Molecular and Biochemical Parasitology · doi:10.1016/0166-6851(94)00156-1 · Cited by 74
Analysis of MRP mRNA in mitoxantrone-selected, multidrug-resistant human tumor cells
Futscher, B. W., Abbaszadegan, M. R., Domann, F. E., & Dalton, W. S. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90538-x · Cited by 73
Drug Resistance Mechanisms in Non-Small Cell Lung Carcinoma
Wangari‐Talbot, J., & Hopper-Borge, E. A. (2013) · Journal of cancer research updates · doi:10.6000/1929-2279.2013.02.04.5 · Cited by 89
“(ABCC1) also known as Multidrug resistance protein 1 (MRP1) is an efflux pump originally discovered in doxorubicin resistant lung carcinoma cells displaying a multi-drug resistant phenotype without ABCB1 expression [150].”
BackgroundEmerging Roles of SRSF3 as a Therapeutic Target for Cancer
Zhou, Z., Gong, Q., Lin, Z., Wang, Y., Li, M., Wang, L., Ding, H., & Li, P. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.577636 · Cited by 73
MRP2 (ABCC2) and cisplatin sensitivity in hepatocytes and human ovarian carcinoma
Guminski, A. D., Balleine, R. L., Chiew, Y.-E., Webster, L. R., Tapner, M. J., Farrell, G. C., Harnett, P. R., & DeFazio, A. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.08.046 · Cited by 80
“The first ABC transporter identified in this context was p-glycoprotein (MDR1, ABCB1) [6], and in the absence of over-expressed MDR1, multi-drug resistance protein 1 (MRP1, ABCC1) was discovered as a cause of the multi-drug resistance phenotype [7].”
BackgroundABC Proteins Protect the Human Body and Maintain Optimal Health
Ueda, K. (2011) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.100816 · Cited by 87
Burg, D., & Mulder, G. J. (2002) · Drug Metabolism Reviews · doi:10.1081/dmr-120015695 · Cited by 83
“MRP1 was then identified as a second drug resistance-related ABC-transporter;([207]) overexpression of this efflux pump causes the typical MDR phenotype in a variety of cell types.”
BackgroundOwen, J. D., Strieter, R., Burdick, M., Haghnegahdar, H., Nanney, L., Shattuck-Brandt, R., & Richmond, A. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970926)73:1<94::aid-ijc15>3.0.co;2-5 · Cited by 133
Drug resistance in lung cancer
Nishio, K., Nakamura, T., Koh, Y., Suzuki, T., Fukumoto, H., & Saijo, N. (1999) · Current Opinion in Oncology · doi:10.1097/00001622-199903000-00006 · Cited by 72
Wosikowski, K., Regis, J. T., Robey, R. W., Alvarez, M. G., Buters, J., Gudas, J. M., & Bates, S. E. (1995) · PubMed · Cited by 78
Reversal of LRP-associated drug resistance in colon carcinoma sw-620 cells
Kitazono, M., Okumura, H., Ikeda, R., Sumizawa, T., Furukawa, T., Nagayama, S., Seto, K., Aikou, T., & Akiyama, S. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20010101)91:1<126::aid-ijc1018>3.0.co;2-8 · Cited by 72
Regulation of organic anion and drug transporters of the sinusoidal membrane
Kullak-Ublick, G. A. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80054-3 · Cited by 77
Ai, Y., Kang, F., Huang, Z., Xue, X., Lai, Y., Peng, S., Tian, J., & Zhang, Y. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm5019302 · Cited by 71
Limtrakul, P. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-46401-5_12 · Cited by 84
Regulation of ABC Transporter Function Via Phosphorylation by Protein Kinases
I. Stolarczyk, E., J. Reiling, C., & M. Paumi, C. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111795164075 · Cited by 71
Leschziner, G. D., Zabaneh, D., Pirmohamed, M., Owen, A., Rogers, J., Coffey, A. J., Balding, D. J., Bentley, D., & Johnson, M. R. (2006) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000197467.21964.67 · Cited by 84
Pharmacogenetics of ATP-Binding Cassette Transporters and Clinical Implications
Cascorbi, I., & Haenisch, S. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-416-6_6 · Cited by 75
Cui, Z., Shiraki, T., Hirata, D., & Miyakawa, T. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.01027.x · Cited by 71
“Recently, an additional member of this ABC superfamily, multidrug resistanceassociated protein (MRP), has been shown to confer a multidrug resistance phenotype similar to that associated with MDR1 (Cole et al., 1992).”
ResultInfluentialEtiévant, C., Barret, J.-M. M., Kruczynski, A., Perrin, D., & Hill, B. T. (1998) · Investigational New Drugs · doi:10.1023/a:1006022811895 · Cited by 71
van Kuijck, M. A., van Aubel, R. A. M. H., Busch, A. E., Lang, F., Rüssel, F. G. M., Bindels, R. J. M., van Os, C. H., & Deen, P. M. T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.11.5401 · Cited by 71
Structural requirements for the apical sorting of human multidrug resistance protein 2 (ABCC2)
Nies, A. T., König, J., Cui, Y., Brom, M., Spring, H., & KEPPLER, D. O. R. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.02832.x · Cited by 69
“MRP1, the first cloned member of the MRP family [2], is present in the plasma membrane of several cell types [3–5].”
BackgroundKauffmann, H.-M., KEPPLER, D. O. R., Gant, T. W., & Schrenk, D. (1998) · Archives of Toxicology · doi:10.1007/s002040050571 · Cited by 75
“…which is predominantly expressed in a number of extrahepatic tissues (Cole et al. 1992; Flens et al. 1996), and plays an important role as a resistance factor in malignant tumours (Cole et al. 1992; Krishnamachary and Center 1993; Leier et al. 1994; Almquist et al. 1995; Jedlitschky et al. 1996).”
Backgroundvan der Pol, M. A., Broxterman, H. J., Pater, J. M., Feller, N., van der Maas, M., Weijers, G. W. D., Scheffer, G. L., Jd, A., Scheper, R. J., van Loevezijn, A., et al. (2003) · PubMed · Cited by 71
Sumizawa, T., Chen, Z., Chuman, Y., Seto, K., Furukawa, T., Haraguchi, M., Tani, A., Shudo, N., & Akiyama, S.-I. (1997) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)13480-3 · Cited by 76
MULTIDRUG RESISTANCE IN LEUKAEMIA
McKenna, S. L., & Padua, R. A. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.d01-2095.x · Cited by 73
“Another member of the ABC superfamily of transporter proteins, the MDR-associated protein (MRP), was discovered in a drugresistant human small cell lung cancer cell line H69AR (Cole et al, 1992).”
BackgroundMolecular modeling of the human multidrug resistance protein 1 (MRP1/ABCC1)
DeGorter, M. K., Conseil, G., Deeley, R. G., Campbell, R. L., & Cole, S. P. C. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.10.141 · Cited by 70
Self-citationRole of BCRP as a biomarker for predicting resistance to 5-fluorouracil in breast cancer
Yuan, J., Lv, H., Peng, B., Wang, C., Yu, Y., & He, Z. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0838-z · Cited by 78
“(MRP/ABCC1) [ 15 ] and the breast cancer resistance protein (BCRP/ABCG2) [1] transporters confer MDR by actively exporting many anticancer drugs from cells.”
BackgroundGuo, B., Villeneuve, D. J., Hembruff, S. L., Kirwan, A. F., Blais, D. E., Bonin, M., & Parissenti, A. M. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000021046.29834.12 · Cited by 70
Overcoming multidrug resistance with nanomedicines
Ganoth, A., Merimi, K. C., & Peer, D. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.960920 · Cited by 74
“2 ABCC1/MRP1 The MRP1, encoded in humans by the ABCC1 gene, was first cloned in 1992 and was identified because of its ability to provide MDR to a lung cancer cell line, H69AR [32].”
BackgroundJi, L., Wei, Y., Jiang, T., & Wang, S. (2014) · Europe PMC (PubMed Central) · Cited by 86
FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10
Xie, T., Geng, J., Wang, Y., Wang, L., Huang, M., Chen, J., Zhang, K., Xue, L., Liu, X., Mao, X., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.14351 · Cited by 70
“ABCC10 is a member of ABC transporter family, which play important roles in drug resistance by effluxing anticancer agents outside of cancer cells [43].”
Rigato, I., Pascolo, L., Fernetti, C., Ostrow, J. D., & Tiribelli, C. (2004) · Biochemical Journal · doi:10.1042/bj20040599 · Cited by 70
Abe, T., Koike, K., Ohga, T., Kubo, T., Wada, M., Kohno, K., Mori, T., Hidaka, K., & Kuwano, M. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.348 · Cited by 70
The importance of drug-transporting P-glycoproteins in toxicology
van Tellingen, O. (2001) · Toxicology Letters · doi:10.1016/s0378-4274(01)00304-6 · Cited by 77
Miller, D. W., Fontain, M., Kolar, C., & Lawson, T. A. (1996) · Cancer Letters · doi:10.1016/0304-3835(96)04384-4 · Cited by 70
Anthracyclines modulate multidrug resistance protein (MRP) mediated organic anion transport
Heijn, M., Hooijberg, J. H., Scheffer, G. L., Szabó, G., Westerhoff, H. V., & Lankelma, J. (1997) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(97)00003-5 · Cited by 75
Arai, E., Sakamoto, H., Ichikawa, H., Totsuka, H., Chiku, S., Gotoh, M., Mori, T., Nakatani, T., Ohnami, S., Nakagawa, T., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28768 · Cited by 75
“In addition, ABC transporters play a crucial role in the development of resistance through efflux of anticancer agents from cancer cells.(46) The disease-free interval of patients with colorectal cancers treated by adjuvant chemotherapy is significantly shorter in patients with low ABCA13 transcript levels.”
BackgroundYin, J., Huang, Q., Yang, Y., Zhang, J., Zhong, M.-Z., Zhou, H.-H., & Liu, Z. (2009) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328323f680 · Cited by 69
Konishi, T., Satsu, H., Hatsugai, Y., Aizawa, K., Inakuma, T., Nagata, S., Sakuda, S., Nagasawa, H., & Shimizu, M. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705804 · Cited by 69
“Multidrug resistance-associated proteins (MRPs), which belong to the ABC transporter superfamily but have different substrate specificity from P-gp, are also known as a factor of multidrug resistance (Cole et al., 1992; Suzuki, 1999).”
BackgroundDrug transport across the placenta, role of the ABC drug efflux transporters
Behravan, J., & Piquette‐Miller, M. (2007) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.3.6.819 · Cited by 81
“in drug-resistant cells not associated with P-gp expression [77] .”
BackgroundCircumvention of multi-drug resistance of cancer cells by Chinese herbal medicines
Chai, S., To, K. K., & Lin, G. (2010) · Chinese Medicine · doi:10.1186/1749-8546-5-26 · Cited by 69
“The second major MDR transporter, multidrug-resistance-associated protein (MRP), was first discovered in a doxorubicin-selected lung cancer cell line [13].”
BackgroundModulation of Oral Drug Bioavailability: From Preclinical Mechanism to Therapeutic Application
Kuppens, I. E. L. M., Breedveld, P., Beijnen, J. H., & Schellens, J. H. M. (2005) · Cancer Investigation · doi:10.1081/cnv-58823 · Cited by 80
“multidrug-resistant cell lines of small cell lung cancer.([27]) It was shown that leukemias with coordinate P-gp and MRP1 function are associated with poorest outcome.”
Backgroundvan Brussel, J. P., van Steenbrugge, G. J., van Krimpen, C., Bogdanowicz, J. F. A. T., van der Kwast, T., Schröder, F. H., & Mickisch, G. (2001) · The Journal of Urology · doi:10.1097/00005392-200101000-00032 · Cited by 69
Role of the lung resistance-related protein (LRP) in the drug sensitivity of cultured tumor cells
Meschini, S., Marra, M., Calcabrini, A., Monti, E., Gariboldi, M. B., Dolfini, E., & Arancia, G. (2002) · Toxicology in Vitro · doi:10.1016/s0887-2333(02)00035-8 · Cited by 69
Koike, K., Conseil, G., Leslie, E. M., Deeley, R. G., & Cole, S. P. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311435200 · Cited by 75
Self-citationVEGF, bFGF and EGF in the angiogenesis of human melanoma xenografts
Danielsen, T., & Rofstad, E. K. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980610)76:6<857::aid-ijc15>3.0.co;2-# · Cited by 73
The c‐MYC‐ABCB5 axis plays a pivotal role in 5‐fluorouracil resistance in human colon cancer cells
Kugimiya, N., Nishimoto, A., Hosoyama, T., Ueno, K., Enoki, T., Li, T., & Hamano, K. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12531 · Cited by 78
“ABCB5, ABCC4 and ABCC5 expression levels, which are closely involved in the resistance to chemotherapeutic agents including 5FU [17–23].”
BackgroundPayen, L. F., Courtois, A., Campion, J. P., Guillouzo, A., & Fardel, O. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00496-2 · Cited by 68
Soldevilla, M. M., Villanueva, H., Casares, N., Lasarte, J. J., Bendandi, M., Inoges, S., de Cerio, A. L.-D., & Pastor, F. (2016) · Oncotarget · doi:10.18632/oncotarget.8095 · Cited by 68
“Multidrug Resistant-associated Protein 1 (MRP1) has been directly correlated with chemotherapy drug resistance in several types of tumors [4, 7-10], and, along with other chemotherapy-resistant proteins, it is highly expressed in cancer stem cells [11-13].”
BackgroundMethodInfluentialDavey, R., Longhurst, T., Davey, M. W., Belov, L., Harvie, R. M., Hancox, D., & Wheeler, H. (1995) · Leukemia Research · doi:10.1016/0145-2126(94)00159-8 · Cited by 68
“associated with non-P-glycoprotein MDR in some but not all non-P-glycoprotein MDR cell lines [4,15,16].”
BackgroundInfluentialMultidrug Resistance in Prostate Cancer
van Brussel, J. P., & Mickisch, G. (2003) · Oncology Research and Treatment · doi:10.1159/000071510 · Cited by 68
“Localized prostate cancer has a good prognosis and can be managed by watchful waiting, early versus deferred hormonal treatment[3] external radiotherapy, brachytherapy or by surgery.”
BackgroundInfluentialCandidate genes for cross-resistance against DNA-damaging drugs.
Wittig, R., Neßling, M., Will, R. D., Mollenhauer, J., Salowsky, R., Münstermann, E., Schick, M., Helmbach, H., Gschwendt, B., Korn, B., et al. (2002) · PubMed · Cited by 72
van der Deen, M., Marks, H., Willemse, B. W. M., Postma, D. S., Müller, M. M., Smit, E. F., Scheffer, G. L., Scheper, R. J., de Vries, E. G. E., & Timens, W. (2006) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-006-0240-3 · Cited by 75
“MRP1 mRNA was first detected in small cell lung cancer and is highly expressed in normal human lung [ 2 , 8, 21].”
Background
Metadata
- Authors
- Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., & Deeley, R. G.
- Affiliations
- Queen's University (CA)
- Venue
- Science
- Published
- 1992-12-04
- Volume
- 258
- Issue
- 5088
- Pages
- 1650-1654
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2168070336
- Cited by
- 3,037
- References
- 47
- Citations by year
- 2026: 12 · 2025: 30 · 2024: 46 · 2023: 55 · 2022: 40 · 2021: 53 · 2020: 61 · 2019: 39 · 2018: 45 · 2017: 55 · 2016: 66 · 2015: 67 · 2014: 79 · 2013: 80 · 2012: 77
- FWCI
- 37.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- multidrug resistance, lung cancer, doxorubicin resistance, ABC transporters, gene amplification, P-glycoprotein, mRNA overexpression, cDNA cloning
- MeSH terms
- Amino Acid Sequence, Animals, Chromosome Banding, Chromosomes, Human, Pair 16, Doxorubicin, Drug Resistance, Gene Amplification, Multigene Family, Humans, Lung, Lung Neoplasms, Male, Membrane Glycoproteins, Molecular Sequence Data, Phylogeny, RNA, Messenger, Testis, Tumor Cells, Cultured, Sequence Homology, Amino Acid, ATP Binding Cassette Transporter, Subfamily B, Member 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.